Syntara Ltd
SNT
Company Profile
Business description
Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The company has various drug candidates in its pipeline such as SNT-5505, SNT-4728, SNT-5382, and SNT-8370 as a potential treatment for cancer, skin scarring, and neuroinflammation.
Contact
20 Rodborough Road
Unit 2
Frenchs Forest
Sydney NSW 2086
AUST: +61 287601480
E: david.mcgarvey@pharmaxis.com.au
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2025
Employees
93
Syntara Ltd News & Analysis
stocks
CSL remains favourite, but biotech field broadening
The biotech giant has jumped 22pc a year for the past decade but new players are emerging.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,456.80 | 39.80 | 0.47% |
| CAC 40 | 7,615.41 | 170.51 | 2.29% |
| DAX 40 | 19,002.38 | 290.89 | 1.55% |
| Dow JONES (US) | 42,025.19 | 522.09 | 1.26% |
| FTSE 100 | 8,328.72 | 75.04 | 0.91% |
| HKSE | 18,067.07 | 53.91 | 0.30% |
| NASDAQ | 18,013.98 | 440.68 | 2.51% |
| Nikkei 225 | 37,893.53 | 738.20 | 1.99% |
| NZX 50 Index | 12,599.38 | 65.62 | -0.52% |
| S&P 500 | 5,713.64 | 95.38 | 1.70% |
| S&P/ASX 200 | 8,228.00 | 36.10 | 0.44% |
| SSE Composite Index | 2,734.23 | 1.79 | -0.07% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Core Lithium Ltd CXO | 0.10 | 0.00 | 0.00% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -7.14% |
| Tabcorp Holdings Ltd TAH | 0.45 | 0.02 | 3.49% |
| Imugene Ltd IMU | 0.05 | 0.00 | 0.00% |
| Appen Ltd APX | 1.85 | 0.06 | 3.06% |
| Pilbara Minerals Ltd PLS | 2.83 | 0.05 | -1.74% |
| Australian Vanadium Ltd AVL | 0.01 | 0.00 | -3.33% |
| Mirvac Group MGR | 2.30 | 0.02 | 0.66% |
| Ioneer Ltd INR | 0.20 | 0.02 | 9.46% |
| Zip Co Ltd ZIP | 2.71 | 0.11 | 4.23% |